The Dutch Flutemetamol in Young Dementia Study.

Trial Profile

The Dutch Flutemetamol in Young Dementia Study.

Phase of Trial: Phase III

Latest Information Update: 02 Feb 2017

At a glance

  • Drugs Flutemetamol-F-18 (Primary)
  • Indications Dementia
  • Focus Biomarker; Diagnostic use; Registrational
  • Most Recent Events

    • 02 Feb 2017 Status changed from recruiting to completed.
    • 16 Jul 2014 Results published in a GE Healthcare media release.
    • 13 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top